Tested Range and Median Concentration of LD70 of Each Drug
| Abbreviation (drug name) . | Tested Range (μg/mL) Maximum-Minimum . | Median . |
|---|---|---|
| . | . | Concentration (μg/mL) of LD70 . |
| DNR (daunorubicin) | 0.8-0.00128 | 0.087 |
| ACR (aclarubicin) | 0.8-0.00128 | 0.08 |
| VP16 (etoposide) | 20-0.032 | 1.05 |
| L-ASP (L-asparaginase) | 10-0.016* | 1.925* |
| THP-ADR (pirarubicin) | 0.8-0.00128 | 0.135 |
| MIT (mitoxantrone) | 0.4-0.00064 | 0.08 |
| L-PAM (melphalan) | 20-0.032 | 5.75 |
| 4HC (4-hydroperoxy-CPA)† | 40-0.064 | 5.2 |
| AraC (cytarabine) | 40-0.064 | 1 |
| MTX (methotrexate) | 500-0.8 | 500 |
| BLM (bleomycine) | 40-0.064 | 40 |
| VCR (vincristine) | 1-0.0016 | 1 |
| VLB (vinblastine) | 10-0.016 | 2.8 |
| MMC (mitomycin C) | 2-0.0032 | 0.3 |
| Pred (prednisolone) | 100-0.16 | 36‡ |
| Dex (dexamethasone) | 4-0.0064 | 35‡ |
| Abbreviation (drug name) . | Tested Range (μg/mL) Maximum-Minimum . | Median . |
|---|---|---|
| . | . | Concentration (μg/mL) of LD70 . |
| DNR (daunorubicin) | 0.8-0.00128 | 0.087 |
| ACR (aclarubicin) | 0.8-0.00128 | 0.08 |
| VP16 (etoposide) | 20-0.032 | 1.05 |
| L-ASP (L-asparaginase) | 10-0.016* | 1.925* |
| THP-ADR (pirarubicin) | 0.8-0.00128 | 0.135 |
| MIT (mitoxantrone) | 0.4-0.00064 | 0.08 |
| L-PAM (melphalan) | 20-0.032 | 5.75 |
| 4HC (4-hydroperoxy-CPA)† | 40-0.064 | 5.2 |
| AraC (cytarabine) | 40-0.064 | 1 |
| MTX (methotrexate) | 500-0.8 | 500 |
| BLM (bleomycine) | 40-0.064 | 40 |
| VCR (vincristine) | 1-0.0016 | 1 |
| VLB (vinblastine) | 10-0.016 | 2.8 |
| MMC (mitomycin C) | 2-0.0032 | 0.3 |
| Pred (prednisolone) | 100-0.16 | 36‡ |
| Dex (dexamethasone) | 4-0.0064 | 35‡ |